Patents by Inventor Boris Schilling

Boris Schilling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230220431
    Abstract: There is provided SHC/HAC derivatives, amino acid sequences comprising the SHC/HAC derivatives, nucleotide sequences encoding the SHC/HAC derivatives, vectors comprising nucleotide sequences encoding the SHC/HAC derivatives, recombinant host cells comprising nucleotide sequences encoding the SHC/HAC derivatives and applications of the recombinant host cells comprising either SHC/HAC derivatives or WT SHC/HAC enzymes in methods to prepare (?)-Ambrox and SHC/HAC enzymes in methods to prepare (?)-Ambrox.
    Type: Application
    Filed: August 31, 2022
    Publication date: July 13, 2023
    Inventors: Eric EICHHORN, Boris SCHILLING, Denis WAHLER, Laurent FOURAGE, Esther LOCHER
  • Publication number: 20230040990
    Abstract: A process for producing rotundone from ?-guaiene, in particular by oxidation of the C(3) position, wherein the ?-guaiene is produced from a precursor by a sesquiterpene synthase. The sesquiterpene synthase is produced in a microorganism.
    Type: Application
    Filed: September 28, 2022
    Publication date: February 9, 2023
    Inventors: Andreas GOEKE, Julie CHARPENTIER, Boris SCHILLING, Fridtjof SCHRÖDER
  • Patent number: 11485985
    Abstract: A process for producing rotundone from ?-guaiene, in particular by oxidation of the C(3) position, wherein the ?-guaiene is produced from a precursor by a sesquiterpene synthase. The sesquiterpene synthase is produced in a microorganism.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: November 1, 2022
    Assignee: Givaudan SA
    Inventors: Andreas Goeke, Julie Charpentier, Boris Schilling, Fridtjof Schröder
  • Patent number: 11466299
    Abstract: There is provided SHC/HAC derivatives, amino acid sequences comprising the SHC/HAC derivatives, nucleotide sequences encoding the SHC/HAC derivatives, vectors comprising nucleotide sequences encoding the SHC/HAC derivatives, recombinant host cells comprising nucleotide sequences encoding the SHC/HAC derivatives and applications of the recombinant host cells comprising either SHC/HAC derivatives or WT SHC/HAC enzymes in methods to prepare (?)-Ambrox and SHC/HAC enzymes in methods to prepare (?)-Ambrox.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: October 11, 2022
    Assignee: GIVAUDAN S.A.
    Inventors: Eric Eichhorn, Boris Schilling, Denis Wahler, Laurent Fourage, Esther Locher
  • Publication number: 20210254112
    Abstract: There is provided SHC/HAC derivatives, amino acid sequences comprising the SHC/HAC derivatives, nucleotide sequences encoding the SHC/HAC derivatives, vectors comprising nucleotide sequences encoding the SHC/HAC derivatives, recombinant host cells comprising nucleotide sequences encoding the SHC/HAC derivatives and applications of the recombinant host cells comprising either SHC/HAC derivatives or WT SHC/HAC enzymes in methods to prepare (?)-Ambrox and SHC/HAC enzymes in methods to prepare (?)-Ambrox.
    Type: Application
    Filed: April 26, 2021
    Publication date: August 19, 2021
    Inventors: Eric EICHHORN, Boris SCHILLING, Denis WAHLER, Laurent FOURAGE, Esther LOCHER
  • Patent number: 11021722
    Abstract: There is provided SHC/HAC derivatives, amino acid sequences comprising the SHC/HAC derivatives, nucleotide sequences encoding the SHC/HAC derivatives, vectors comprising nucleotide sequences encoding the SHC/HAC derivatives, recombinant host cells comprising nucleotide sequences encoding the SHC/HAC derivatives and applications of the recombinant host cells comprising either SHC/HAC derivatives or WT SHC/HAC enzymes in methods to prepare (?)-Ambrox and SHC/HAC enzymes in methods to prepare (?)-Ambrox.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: June 1, 2021
    Assignee: GIVAUDAN S.A.
    Inventors: Eric Eichhorn, Boris Schilling, Denis Wahler, Laurent Fourage, Esther Locher
  • Publication number: 20200299737
    Abstract: A process for producing rotundone from ?-guaiene, in particular by oxidation of the C(3) position, wherein the ?-guaiene is produced from a precursor by a sesquiterpene synthase. The sesquiterpene synthase is produced in a microorganism.
    Type: Application
    Filed: November 21, 2018
    Publication date: September 24, 2020
    Inventors: Andreas GOEKE, Julie CHARPENTIER, Boris SCHILLING, Fridtjof SCHRÖDER
  • Publication number: 20200040369
    Abstract: There is provided SHC/HAC derivatives, amino acid sequences comprising the SHC/HAC derivatives, nucleotide sequences encoding the SHC/HAC derivatives, vectors comprising nucleotide sequences encoding the SHC/HAC derivatives, recombinant host cells comprising nucleotide sequences encoding the SHC/HAC derivatives and applications of the recombinant host cells comprising either SHC/HAC derivatives or WT SHC/HAC enzymes in methods to prepare (?)-Ambrox and SHC/HAC enzymes in methods to prepare (?)-Ambrox.
    Type: Application
    Filed: October 10, 2019
    Publication date: February 6, 2020
    Inventors: Eric EICHHORN, Boris SCHILLING, Denis WAHLER, Laurent FOURAGE, Esther LOCHER
  • Patent number: 10472655
    Abstract: There is provided SHC/HAC derivatives, amino acid sequences comprising the SHC/HAC derivatives, nucleotide sequences encoding the SHC/HAC derivatives, vectors comprising nucleotide sequences encoding the SHC/HAC derivatives, recombinant host cells comprising nucleotide sequences encoding the SHC/HAC derivatives and applications of the recombinant host cells comprising either SHC/HAC derivatives or WT SHC/HAC enzymes in methods to prepare (?)-Ambrox and SHC/HAC enzymes in methods to prepare (?)-Ambrox.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: November 12, 2019
    Assignee: GIVAUDAN S.A.
    Inventors: Eric Eichhorn, Boris Schilling, Denis Wahler, Laurent Fourage, Esther Locher
  • Publication number: 20180187123
    Abstract: A perfume complement comprising one or more compounds selected from compounds present in the fraction of patchouli oil having a Kovats Retention Index on a DB-5 column of 1500 or lower and/or olfactively equivalent perfume ingredients
    Type: Application
    Filed: September 23, 2016
    Publication date: July 5, 2018
    Inventors: Robin CLERY, Sandro DOSSENBACH, Dominique LELIEVRE, Boris SCHILLING
  • Publication number: 20180148751
    Abstract: There is provided SHC/HAC derivatives, amino acid sequences comprising the SHC/HAC derivatives, nucleotide sequences encoding the SHC/HAC derivatives, vectors comprising nucleotide sequences encoding the SHC/HAC derivatives, recombinant host cells comprising nucleotide sequences encoding the SHC/HAC derivatives and applications of the recombinant host cells comprising either SHC/HAC derivatives or WT SHC/HAC enzymes in methods to prepare (?)-Ambrox and SHC/HAC enzymes in methods to prepare (?)-Ambrox.
    Type: Application
    Filed: April 22, 2016
    Publication date: May 31, 2018
    Inventors: Eric EICHHORN, Boris SCHILLING, Denis WAHLER, Laurent FOURAGE, Esther LOCHER
  • Patent number: 9012169
    Abstract: The invention is concerned with the identification of compounds as flavors or fragrances, their precursors, or as modulators of the perception of fragrances or flavors. The method comprises a reaction of a compound with a metabolic enzyme expressed in the nose, mouth or respiratory tract, followed by a method of identification of the compound or its metabolites as a fragrance or flavor, their precursor, or a modulator of their perception or of the perception of their respective leads.
    Type: Grant
    Filed: July 15, 2005
    Date of Patent: April 21, 2015
    Assignee: Givaudan S.A.
    Inventor: Boris Schilling
  • Patent number: 8883468
    Abstract: (3S,5R)-3,8-dimethyl-5-(prop-1-en-2-yl)-octahydroazulen-1-ols, their use as flavor or fragrance ingredient, and a process of their production by oxidation in the presence of laccase.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: November 11, 2014
    Assignee: Givaudan S.A.
    Inventors: Boris Schilling, Thierry Granier, Esther Locher
  • Publication number: 20130089904
    Abstract: (3S,5R)-3,8-dimethyl-5-(prop-1-en-2-yl)-octahydroazulen-1-ols, their use as flavour or fragrance ingredient, and a process of their production by oxidation in the presence of laccase.
    Type: Application
    Filed: June 28, 2011
    Publication date: April 11, 2013
    Applicant: GIVAUDAN S.A.
    Inventors: Boris Schilling, Thierry Granier, Esther Locher
  • Publication number: 20110200549
    Abstract: Disclosed are compounds having the ability to modulate, namely to improve, enhance and/or modify fragrance compositions due to their ability to inhibit cytochrome P450 enzymes, e.g. CYP2A, e.g. 2A13 and 2A6, and CYP2B6.
    Type: Application
    Filed: September 29, 2009
    Publication date: August 18, 2011
    Inventors: Thierry Granier, Boris Schilling
  • Publication number: 20100191019
    Abstract: The invention refers to conjugated secondary alkatrienol derivatives, a method of their production and to flavour and perfume compositions comprising them.
    Type: Application
    Filed: July 15, 2008
    Publication date: July 29, 2010
    Inventors: Thierry Granier, Boris Schilling
  • Publication number: 20100113460
    Abstract: Disclosed are compounds having the ability to inhibit cytochrome P450 2A6, 2A13, and/or 2B6 and tobacco products comprising them. Also disclosed are pharmaceutical compositions comprising them.
    Type: Application
    Filed: March 20, 2008
    Publication date: May 6, 2010
    Applicant: Givaudan SA
    Inventors: Boris Schilling, Wolf D. Woggon, Antoinette Chougnet, Thierry Granier, Georg Frater, Andreas Hanhart
  • Publication number: 20100111888
    Abstract: Disclosed are compounds having the ability to modulate, namely to improve, enhance and or modify fragrance compositions due to their ability to inhibit cytochrome P450 enzymes, e.g. CYP2A13 and CYP2B6.
    Type: Application
    Filed: March 20, 2008
    Publication date: May 6, 2010
    Applicant: GIVAUDAN SA
    Inventors: Boris Schilling, Thierry Granier, Georg Frater, Andreas Hanhart
  • Patent number: 7638343
    Abstract: The invention relates to methods of identification or evaluation of compounds useful in the field of fragrances and aromas (the volatile part of a flavor). Methods according to the invention take into account the occurrence of enzymatic metabolism in the human respiratory tract, including the oral and in particular the nasal cavity.
    Type: Grant
    Filed: July 15, 2005
    Date of Patent: December 29, 2009
    Inventor: Boris Schilling
  • Publication number: 20080166735
    Abstract: The invention is concerned with the identification of compounds as flavours or fragrances, their precursors, or as modulators of the perception of fragrances or flavours. The method comprises a reaction of a compound with a metabolic enzyme expressed in the nose, mouth or respiratory tract, followed by a method of identification of the compound or its metabolites as a fragrance or flavour, their precursor, or a modulator of their perception or of the perception of their respective leads.
    Type: Application
    Filed: July 15, 2005
    Publication date: July 10, 2008
    Inventor: Boris Schilling